LAMBDA-CAP Trademark
LAMBDA-CAP is a USPTO trademark filed by Numab Therapeutics AG. Status: Registered.
Trademark Facts
| Mark | LAMBDA-CAP |
|---|---|
| Serial Number | 79250615 |
| Registration Number | 5980170 |
| Status | Registered |
| Filing Date | 2018-12-03 |
| Registration Date | 2020-02-11 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Numab Therapeutics AG |
| Attorney of Record | Dennis S. Prahl |
| Prosecution Events | 32 |
| Latest Event | ES75 on 2026-02-05 |
Goods & Services
Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products; Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research